Hemostemix Inc. is pleased to announce the Journal of Biomedical Research and Environmental Sciences published the Company s Phase II randomized clinical trial results today.The publication.
Hemostemix Inc.: Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Hemostemix Clarifies its October 3, 2023 News Release streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Hemostemix Inc. is pleased to like to clarify its press release of October 3, 2023. It refered to the private placement of $320,125. The Company closed the financing in the amount of $320,385 with.
Hemostemix Inc. is pleased to announce that Stem Cell Research & Therapy published the Company s seventh peer reviewed study of ACP-01 - the third peer reviewed study of ACP-01 as a treatment for.